GSK celebrates 100 years in India with former MDs, highlighting resilience and reinvention in the pharmaceutical industry.
New York Post on MSN6d
FDA proposes ending use of popular decongestant in cold medicinesThe US Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough syrups.
Pharmaceutical stocks declined as President-elect Donald Trump said he’s tapping Robert F. Kennedy Jr. to run the Department ...
Phenylephrine is widely used in a variety of over-the-counter flu and cold medicines, including popular products such as Benadryl ... the ingredient Companies such as Procter & Gamble and GSK were ...
As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...
(Reuters) -The U.S. Food and Drug Administration has proposed to remove oral phenylephrine, widely used in cold and cough ...
What’s an example of a well-executed drug launch? Look no further than Reata’s commercialization of Skyclarys, the first ...
Controller medications, also known as daily maintenance medications, are a critical tool for managing asthma — reducing daily ...
In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...
and GSK (GSK). Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See today’s best-performing stocks on TipRanks >> Read More on MRNA: ...
The company has important products such as Shingrix and ... enhances patient adherence, making it a top-selling product. Unfortunately, GSK has been facing litigation risks that may drag its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback